Overview

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.
Phase:
Phase 4
Details
Lead Sponsor:
Teva Neuroscience, Inc.
Teva Pharmaceutical Industries
Treatments:
(T,G)-A-L
Glatiramer Acetate